Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit.
Neuronal acetylcholine nicotinic receptors (nAChR) are composed of 12 subunits (alpha2-10, beta2-4), of which alpha3, alpha5, alpha7, beta2 and beta4 subunits are known to exist in the autonomic nervous system (ANS). alpha5 subunits possess unique biophysical and pharmacological properties. The present study was undertaken to examine the functional role and pharmacological properties of the nAChR alpha5 subunits in the ANS using mice lacking alpha5 nAChR subunits (alpha5-/-). These mice grew to normal size showing no obvious physical or neurological deficit. They also showed normality in thermoregulation, pupil size and resting heart rate under physiological conditions. The heart rate and rectal temperature did not differ between alpha5-/- and wild-type mice during exposure to cold stress. An impairment of cardiac parasympathetic ganglionic transmission was observed during high frequency vagal stimulation, which caused cardiac arrest in all wild-type animals while alpha5-/- mice were more resistant. Deficiency of alpha5 subunits strikingly increased the sensitivity to a low concentration of hexamethonium, leading to a nearly complete blockade of bradycardia in response to vagal stimulation. Such a concentration of hexamethonium only slightly depressed the effects of vagal stimulation in control mice. Deficiency of alpha5 subunits significantly increased ileal contractile responses to cytisine and epibatidine. These results suggest that alpha5 subunits may affect the affinity and sensitivity of agonists and antagonists in the native receptors. Previous studies revealed that alpha5 subunits form functional receptors only in combination with other alpha and beta subunits. Thus, the data presented here imply that alpha5 subunits modulate the activity of nAChR in autonomic ganglia in vivo.
Wang
Ningshan
N
Department of Physiology and Pharmacology, Sackler Medical School, Tel Aviv University, Israel.
Orr-Urtreger
Avi
A
Chapman
Joab
J
Rabinowitz
Ruth
R
Nachman
Rachel
R
Korczyn
Amos D
AD
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D001341:Autonomic Nervous System / Q000502:physiology*; D001392:Azocines; D001833:Body Temperature Regulation / Q000187:drug effects / Q000502:physiology*; D003433:Crosses, Genetic; D004246:Dimethylphenylpiperazinium Iodide / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000502:physiology*; D007082:Ileum / Q000502:physiology; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000502:physiology*; D009538:Nicotine / Q000494:pharmacology; D021122:Protein Subunits; D011680:Pupil / Q000502:physiology; D011807:Quinolizines; D011978:Receptors, Nicotinic / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D000093843:Quinolizidine Alkaloids
D000470:Alkaloids; D001392:Azocines; D004246:Dimethylphenylpiperazinium Iodide; D009020:Morphine; D009538:Nicotine; D021122:Protein Subunits; D011807:Quinolizines; D011978:Receptors, Nicotinic; C004712:cytisine; D000093843:Quinolizidine Alkaloids